Lazard Asset Management LLC Neuro Pace Inc Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,427 shares of NPCE stock, worth $42,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,427
Previous 3,426
0.03%
Holding current value
$42,494
Previous $25,000
8.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
56Shares Held
21.1MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.27MShares$65.4 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$42.2 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$30.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$30.2 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$15.5 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $308M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...